SEC Form 4 · accession 0000899243-17-016855
Seres Therapeutics, Inc. · MCRB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis A Ausiello
Director
Period of report
Jun 20, 2017
Accepted (ET)
Jun 21, 2017 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609809
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.21 | Jun 20, 2017 | A | 15,000 | A | — | Jun 19, 2027 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option vests in full on the earlier of June 20, 2018 or the day immediately prior to the company's 2018 annual meeting of shareholders.
Remarks
Exhibit List Exhibit 24 - Power of Attorney